Global Nucleic Acid Isolation and Purification Market was valued at USD 3359.84 Million in the year 2020. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market. The market for nucleic acid isolation and purification is expected to grow significantly in the coming years, owing to the key factors such as growing advancements in clinical diagnostic techniques, increasing public-private funding for life science research and increasing automation across the globe.
Nucleic acid isolation and purification is essential for a variety of medical applications such as drug discovery, research and others. The need for high quality, highly pure nucleic acid such as DNA and RNA are an essential for a wide variety of research and clinical applications.
Kits accounted for the largest share of the market among product type segment. Growth in this market can be attributed to the low cost and easy usage of kits in applications such as gene sequencing, molecular diagnostics, and gene cloning. On the other hand, the instruments segment is expected to register the highest CAGR during the forecast period. Additionally, Reagents will be followed by High kits and Instruments will also boost the nucleic acid isolation and purification market in coming years.
Among the regions, North America accounted for the largest share of the nucleic acid isolation and purification market in 2020. Factors such as significant R&D spending in biotechnology and pharmaceutical companies, technological advancements, and government support are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
Scope of the Report
Key Target Audience
Nucleic acid isolation and purification is essential for a variety of medical applications such as drug discovery, research and others. The need for high quality, highly pure nucleic acid such as DNA and RNA are an essential for a wide variety of research and clinical applications.
Kits accounted for the largest share of the market among product type segment. Growth in this market can be attributed to the low cost and easy usage of kits in applications such as gene sequencing, molecular diagnostics, and gene cloning. On the other hand, the instruments segment is expected to register the highest CAGR during the forecast period. Additionally, Reagents will be followed by High kits and Instruments will also boost the nucleic acid isolation and purification market in coming years.
Among the regions, North America accounted for the largest share of the nucleic acid isolation and purification market in 2020. Factors such as significant R&D spending in biotechnology and pharmaceutical companies, technological advancements, and government support are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific region is expected to grow at the highest CAGR during the forecast period.
Scope of the Report
- The report analyses Nucleic Acid Isolation and Purification Market By Value.
- The report analyses Nucleic Acid Isolation and Purification Market Product Type (High Kits, Reagents, Instruments).
- The report further assesses the Nucleic Acid Isolation and Purification Market By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Others).
- The report further assesses the Nucleic Acid Isolation and Purification Market By End User (Hospitals &Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies, Others)
- The Global Nucleic Acid Isolation and Purification Market has been analysed By Region (North America, Europe, Asia Pacific and ROW) and By Country (United States, Canada, Germany, France, U.K, Italy, China, Japan, India, South Korea).
- The key insights of the report have been presented through the frameworks of Major Mergers & Acquisitions, Technological Innovations, and Role of Manufacturers during COVID Pandemic. Also, the attractiveness of the market has been presented By Region, By Product, By Application, and By End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include QIAGEN, Illumina Inc., Danaher, F. Hoffman-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., Promega Corporation, Norgen Biotek Corp.
- The report presents the analysis of Nucleic Acid Isolation and Purification Market for the historical period of 2016-2020 and the forecast period of 2021-2026.
Key Target Audience
- Research Institutions
- Healthcare and Pharmaceutical Companies
- Hospitals and Healthcare Units
- Consulting and Advisory Firms
- Investment Banks and Equity Firms
Table of Contents
1. Research Methodology and Executive Summary1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
3. Nucleic Acid Isolation and Purification Market: Product Outlook
4. Global Nucleic Acid Isolation and Purification Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2021-2026
5. Global Nucleic Acid Isolation and Purification Market Segmentation: An Analysis (2016-2026)
5.1 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Product Type
5.1.1 High Kits - Market Size and Forecast (2016-2026)
5.1.2 Reagents - Market Size and Forecast (2016-2026)
5.1.3 Instruments - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Application Type
5.2.1 Diagnostics - Market Size and Forecast (2016-2026)
5.2.2 Drug Discovery & Development - Market Size and Forecast (2016-2026)
5.2.3 Personalized Medicine - Market Size and Forecast (2016-2026)
5.2.4 Agriculture & Animal Research - Market Size and Forecast (2016-2026)
5.2.5 Others - Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By End user
5.3.1 Hospitals & Diagnostic Centers - Market Size and Forecast (2016-2026)
5.3.2 Academic & Research Institutes - Market Size and Forecast (2016-2026)
5.3.3 Pharmaceuticals & Biotechnology Companies - Market Size and Forecast (2016-2026)
5.3.4 Others - Market Size and Forecast (2016-2026)
6. Global Nucleic Acid Isolation and Purification Market: Regional Analysis
6.1 Competitive Scenario of Global Nucleic Acid Isolation and Purification Market: By Region
7. North America Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)
7.1 North America Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
7.2 North America Nucleic Acid Isolation and Purification Market - Prominent Companies
7.3 Market Segmentation By Product Type (High Kits, Reagents and Instruments)
7.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
7.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
7.6 North America Nucleic Acid Isolation and Purification Market: Country Analysis
7.7 Market Opportunity Chart of North America Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
7.8 Competitive Scenario of North America Nucleic Acid Isolation and Purification Market: By Country
7.9 United States Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
7.10 United States Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
7.11 Canada Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
7.12 Canada Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
8. Europe Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)
8.1 Europe Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
8.2 Europe Nucleic Acid Isolation and Purification Market - Prominent Companies
8.3 Market Segmentation By Product Type ( High Kits, Reagents and Instruments)
8.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
8.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
8.6 Europe Nucleic Acid Isolation and Purification Market: Country Analysis
8.7 Market Opportunity Chart of Europe Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
8.8 Competitive Scenario of Europe Nucleic Acid Isolation and Purification Market: By Country
8.9 Germany Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
8.10 Germany Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
8.11 France Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
8.12 France Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
8.13 United Kingdom Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
8.14 United Kingdom Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
8.15 Italy Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
8.16 Italy Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
9. Asia Pacific Nucleic Acid Isolation and Purification Market: An Analysis (2016-2026)
9.1 Asia Pacific Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Nucleic Acid Isolation and Purification Market - Prominent Companies
9.3 Market Segmentation By Product Type ( High Kits, Reagents and Instruments)
9.4 Market Segmentation By Application Type (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research and Others)
9.5 Market Segmentation By End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceuticals & Biotechnology Companies and Others)
9.6 Asia Pacific Nucleic Acid Isolation and Purification Market: Country Analysis
9.7 Market Opportunity Chart of Asia Pacific Nucleic Acid Isolation and Purification Market - By Country, By Value, 2025
9.8 Competitive Scenario of Asia Pacific Nucleic Acid Isolation and Purification Market: By Country
9.9 China Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
9.10 China Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
9.11 Japan Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
9.12 Japan Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
9.13 India Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
9.14 India Medical Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
9.15 South Korea Nucleic Acid Isolation and Purification Market: Size and Forecast (2016-2026), By Value
9.16 South Korea Nucleic Acid Isolation and Purification Market Segmentation - By Product Type, By Application Type and By End User (2016-2026)
10. Global Nucleic Acid Isolation and Purification Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Product Type, 2026
11.2 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Application Type, 2026
11.3 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By End User, 2026
11.4 Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13.Regulatory Compliance
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 QIAGEN
14.2 Illumina Inc.
14.3 Danaher
14.4 F. Hoffman Roche Ltd.
14.5 Merck KGaA
14.6 Thermo Fisher Scientific Inc.
14.7 Agilent Technologies
14.8 Bio-Rad Laboratories Inc.
14.9 Promega Corporation
14.10 Norgen Biotek Corp.List of Figures
Figure 1: Global Nucleic Acid Isolation and Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 2: Global Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 3: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 4: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 5: Global Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 6: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 7: Global Number of Intensive Care Beds, 2020 (In Numbers)
Figure 8: Global Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 9: Global Nucleic Acid Isolation and Purification Market, By Product, 2020, 2026
Figure 10: Global Nucleic Acid Isolation and Purification Market - By High Kits, By Value (USD Million), 2016-2026
Figure 11: Global Nucleic Acid Isolation and Purification Market - By Reagents, By Value (USD Million), 2016-2026
Figure 12: Global Nucleic Acid Isolation and Purification Market - By Instruments, By Value (USD Million), 2016-2026
Figure 13: Global Nucleic Acid Isolation and Purification Market, By Application, 2020, 2026
Figure 14: Global Nucleic Acid Isolation and Purification Market - By Diagnostics, By Value (USD Million), 2016-2026
Figure 15: Global Nucleic Acid Isolation and Purification Market - By Drug Discovery & Development, By Value (USD Million), 2016-2026
Figure 16: Global Nucleic Acid Isolation and Purification Market - By Personalized Medicine, By Value (USD Million), 2016-2026
Figure 17: Global Nucleic Acid Isolation and Purification Market - By Agriculture & Animal Research, By Value (USD Million), 2016-2026
Figure 18: Global Nucleic Acid Isolation and Purification Market - By Others, By Value (USD Million), 2016-2026
Figure 19: Global Nucleic Acid Isolation and Purification Market, By End User, 2020, 2026
Figure 20: Global Nucleic Acid Isolation and Purification Market - By Hospitals & Diagnostic Centers, By Value (USD Million), 2016-2026
Figure 21: Global Nucleic Acid Isolation and Purification Market - By Academic & Research Institute, By Value (USD Million), 2016-2026
Figure 22: Global Nucleic Acid Isolation and Purification Market - By Pharmaceuticals & Biotechnology Companies, By Value (USD Million), 2016-2026
Figure 23: Global Nucleic Acid Isolation and Purification Market - By Others, By Value (USD Million), 2016-2026
Figure 24: Global Nucleic Acid Isolation and Purification Market, By Region, 2020, 2026
Figure 25: North America Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD
Figure 26: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 27: North America Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 28: North America Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 29: North America Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 30: North America Number of Intensive Care Beds, 2020 (In Numbers)
Figure 31: North America Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 32: North America Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 33: North America Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 34: North America Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 35: Market Opportunity Chart of North America Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
Figure 36: North America Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
Figure 37: United State Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 38: United State Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 39: United State Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 40: United State Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 41: United StateNumber of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 42: United State Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 43: United State Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 44: United State Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 45: Canada Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 46: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 47: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 48: Canada Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 49: Canada Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 50: Canada Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 51: Canada Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 52: Canada Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 53: Europe Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 54: Europe Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 55: Europe Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 56: Europe Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 57: Europe Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 58: Europe Number of Intensive Care Beds, 2020 (In Numbers)
Figure 59: Europe Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 60: Europe Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 61: Europe Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 62: Europe Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 63: Market Opportunity Chart of Europe Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
Figure 64: Europe Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
Figure 65: Germany Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 66: Germany Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 67: Germany Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 68: Germany Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 69: Germany Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 70: Germany Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 71: Germany Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 72: Germany Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 73: France Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 74: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 75: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 76: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 77: France Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 78: France Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 79: France Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 80: France Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 81: United Kingdom Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 82: United Kingdom Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 83: United Kingdom Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 84: United Kingdom Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 85: United Kingdom Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 86: United Kingdom Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 87: United Kingdom Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 88: United Kingdom Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 89: Italy Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 90: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 91: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 92: Italy Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 93: Italy Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 94: Italy Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 95: Italy Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 96: Italy Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 97: Asia Pacific Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 98: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 99: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 100: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 101: Asia Pacific Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 102: Asia Number of Intensive Care Beds, 2020 (In Numbers)
Figure 103: Asia pacific Number of Confirmed COVID19 Deaths, Feb 2021 (In Per Million People)
Figure 104: Asia Pacific Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 105: Asia Pacific Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 106: Asia Pacific Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 107: Market Opportunity Chart of Asia Pacific Nucleic Acid Isolation and Purification Market - By Country, By Value, 2026
Figure 108: Asia Pacific Nucleic Acid Isolation and Purification Market, By Country, 2020, 2026
Figure 109: China Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 110: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 111: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 112: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 113: China Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 114: China Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 115: China Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 116: China Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 117: Japan Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 118: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 119: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Figure 120: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 121: Japan Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 122: Japan Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 123: Japan Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 124: Japan Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 125: India Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 126: India Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 127: India Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 128: India Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 129: India Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 130: India Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 131: India Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 132: India Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 133: South Korea Nucleic Acid Isolation & Purification Market Size, By Value, 2016-2026 (USD Million)
Figure 134: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Figure 135: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Figure 136: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
Figure 137: South Korea Number of deaths in 2020, all cancers, males and females, all ages, (In Numbers)
Figure 138: South Korea Nucleic Acid Isolation & Purification Market - By Product, By Value, 2016-2026 (USD Million)
Figure 139: South Korea Nucleic Acid Isolation & Purification Market - By Application, By Value, 2016-2026 (USD Million)
Figure 140: South Korea Nucleic Acid Isolation & Purification Market - By End User, By Value, 2016-2026 (USD Million)
Figure 141: Market Attractiveness of Global Nucleic Acid Isolation and Purification Market - By Product Type, 2026
Figure 142: Market Attractiveness of Global Nucleic Acid Isolation and Purification Market - By Application, 2026
Figure 143: Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By End User, 2026
Figure 144: Market Attractiveness Chart of Global Nucleic Acid Isolation and Purification Market - By Region, 2026
Figure 145: Market Share of Leading Global Nucleic Acid Isolation and Purification Companies, 2019 (In %)
Figure 146: Qiagen Revenue, 2015-2019 (In USD Million)
Figure 147: Qiagen Revenue, By Business Segment, 2018 (In %)
Figure 148: Qiagen Revenue, By Business Segment, 2019 (In %)
Figure 149: Qiagen Net Revenue, By Region, 2018 (In %)
Figure 150: Qiagen Net Revenue, By Region, 2019 (In %)
Figure 151: Illumina Inc. Revenue, 2016-2019 (In USD Million)
Figure 152: Illumina Inc. Net Revenue, By Business Segment, 2018 (In %)
Figure 153: Illumina Inc. Net Revenue, By Business Segment, 2019 (In %)
Figure 154: Illumina Inc. Net Revenue, By Region, 2018 (In %)
Figure 155: Illumina Inc. Net Revenue, By Region, 2019 (In %)
Figure 156: Danaher Revenue, 2015-2019 (In USD Million)
Figure 157: Danaher Net Revenue, By Business Segment, 2018 (In %)
Figure 158: Danaher Net Revenue, By Business Segment, 2019 (In %)
Figure 159: Danaher Net Revenue, By Geographic Segment, 2018 (In %)
Figure 160: Danaher Net Revenue, By Geographic Segment, 2019 (In %)
Figure 161: F. Hoffman-La Roche Ltd Revenue, 2015-2019 (In USD Million)
Figure 162: F. Hoffman-La Roche Net Sales, By Business Segment, 2018 (In %)
Figure 163: F. Hoffman-La Roche Net Sales, By Business Segment, 2019 (In %)
Figure 164: Merck KGaA Revenue, 2015-2019 (In USD Million)
Figure 165: Merck KGaA Net Sales, By Business Segment, 2018 (In %)
Figure 166: Merck KGaA Net Sales, By Business Segment, 2019 (In %)
Figure 167: Merck KGaA Net Sales, By Geographical Region, 2018 (In %)
Figure 168: Merck KGaA Net Sales, By Geographical Region, 2019 (In %)
Figure 169: Thermo Fisher Scientific Inc. Revenue, 2015-2019 (In USD Million)
Figure 170: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2018 (In %)
Figure 171: Thermo Fisher Scientific Inc Net Sales, By Business Segment, 2019 (In %)
Figure 172: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2018 (In %)
Figure 173: Thermo Fisher Scientific Inc Net Sales, By Geographical Region, 2019 (In %)
Figure 174: Agilent Technologies Revenue, 2015-2019 (In USD Million)
Figure 175: Agilent Technologies Net Sales, By Business Segment, 2018 (In %)
Figure 176: Agilent Technologies Net Sales, By Business Segment, 2019 (In %)
Figure 177: Bio-Rad Laboratories Inc. Revenue, 2015-2019 (In USD Million)
Figure 178: Bio-Rad Laboratories Inc. Net Sales, By Business Segment, 2018 (In %)
Figure 179: Bio-Rad Laboratories Inc. Net Sales, By Business Segment, 2019 (In %)
Figure 180: Bio-Rad Laboratories Inc. Net Sales, By Geographical Region, 2018 (In %)
Figure 181: Bio-Rad Laboratories Inc. Net Sales, By Geographical Region, 2019 (In %)
Companies Mentioned
- QIAGEN
- Illumina Inc.
- Danaher
- F. Hoffman-La Roche Ltd.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Bio-Rad Laboratories Inc.
- Promega Corporation
- Norgen Biotek Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | March 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 3.54 Billion |
| Forecasted Market Value ( USD | $ 5.2 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
